Elanco Animal Health Incorporated (ELAN)

USD 11.73

(-4.71%)

Total Debt Summary of Elanco Animal Health Incorporated

Elanco Animal Health Incorporated's latest annual total debt in 2023 was 5.77 Billion USD , down -1.06% from previous year.
Elanco Animal Health Incorporated's latest quarterly total debt in 2024 Q2 was 5.67 Billion USD , down -1.54% from previous quarter.
Elanco Animal Health Incorporated reported annual total debt of 5.83 Billion USD in 2022, down -7.64% from previous year.
Elanco Animal Health Incorporated reported annual total debt of 6.31 Billion USD in 2021, up 3.14% from previous year.
Elanco Animal Health Incorporated reported quarterly total debt of 5.67 Billion USD for 2024 Q2, down -1.54% from previous quarter.
Elanco Animal Health Incorporated reported quarterly total debt of 5.77 Billion USD for 2023 FY, down -1.06% from previous quarter.

Annual Total Debt Chart of Elanco Animal Health Incorporated (2023 - 2016)

Historical Annual Total Debt of Elanco Animal Health Incorporated (2023 - 2016)

Year	Total Debt	Total Debt Growth
2023	5.77 Billion USD	-1.06%
2022	5.83 Billion USD	-7.64%
2021	6.31 Billion USD	3.14%
2020	6.12 Billion USD	160.17%
2019	2.35 Billion USD	-4.74%
2018	2.47 Billion USD	0.0%
2017	- USD	0.0%
2016	- USD	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	5.76 Billion USD	-0.16%
2024 Q2	5.67 Billion USD	-1.54%
2023 FY	5.77 Billion USD	-1.06%
2023 Q1	6.02 Billion USD	3.15%
2023 Q2	6.06 Billion USD	0.7%
2023 Q3	5.9 Billion USD	-2.52%
2023 Q4	5.77 Billion USD	-2.28%
2022 Q2	6.06 Billion USD	-1.16%
2022 FY	5.83 Billion USD	-7.64%
2022 Q4	5.83 Billion USD	-1.1%
2022 Q3	5.9 Billion USD	-2.67%
2022 Q1	6.13 Billion USD	-2.93%
2021 Q2	6.09 Billion USD	-1.04%
2021 Q3	6.33 Billion USD	3.89%
2021 FY	6.31 Billion USD	3.14%
2021 Q4	6.31 Billion USD	-0.24%
2021 Q1	6.16 Billion USD	0.56%
2020 Q1	2.06 Billion USD	-12.46%
2020 Q2	2.05 Billion USD	-0.26%
2020 Q3	6.14 Billion USD	198.6%
2020 FY	6.12 Billion USD	160.17%
2020 Q4	6.12 Billion USD	-0.21%
2019 Q4	2.35 Billion USD	-0.22%
2019 Q1	2.46 Billion USD	-0.27%
2019 Q3	2.36 Billion USD	-2.03%
2019 FY	2.35 Billion USD	-4.74%
2019 Q2	2.4 Billion USD	-2.29%
2018 Q1	- USD	0.0%
2018 FY	2.47 Billion USD	0.0%
2018 Q4	2.47 Billion USD	-0.25%
2018 Q3	2.47 Billion USD	0.0%
2018 Q2	- USD	0.0%
2017 Q1	- USD	0.0%
2017 Q4	- USD	0.0%
2017 FY	- USD	0.0%
2016 FY	- USD	0.0%

Peer Total Debt Comparison of Elanco Animal Health Incorporated

Name	Total Debt	Total Debt Difference
Amneal Pharmaceuticals, Inc.	2.75 Billion USD	-109.924%
Bausch Health Companies Inc.	22.38 Billion USD	74.209%
Catalent, Inc.	4.98 Billion USD	-15.758%
Emergent BioSolutions Inc.	877.5 Million USD	-558.006%
Perrigo Company plc	4.07 Billion USD	-41.749%
Teva Pharmaceutical Industries Limited	20.15 Billion USD	71.349%
Zoetis Inc.	6.8 Billion USD	15.126%